Longevity Health Holdings Inc.
XAGE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $1 | $0 |
| % Growth | -15.4% | -1.3% | 2,819.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48.7% | 60.1% | 52.9% | 93% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $2 | $1 | $1 |
| SG&A Expenses | $1 | $2 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $1 |
| Operating Income | -$1 | -$2 | -$2 | -$1 |
| % Margin | -345.4% | -369.1% | -295.2% | -5,760.5% |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$1 | -$2 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$1 | -$2 | -$2 | -$1 |
| % Margin | -335.7% | -374.6% | -295.1% | -5,230.8% |
| EPS | -0.83 | -0.09 | -0.072 | -0.044 |
| % Growth | -820.2% | -25.3% | -64.8% | – |
| EPS Diluted | -0.83 | -0.09 | -0.072 | -0.044 |
| Weighted Avg Shares Out | 2 | 21 | 21 | 21 |
| Weighted Avg Shares Out Dil | 2 | 21 | 21 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$1 | -$1 |
| % Margin | -352.7% | -361% | -279.6% | -5,523.8% |